The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Orbimed Capital Gp Iv Llc since year 2005.
The trader's CIK number is 1502240.
At the time of this reporting, Orbimed Capital Gp Iv Llc is the 10% Owner of Principia Biopharma Inc. .
(stock ticker symbol PRNB).
See this page for all insider trading activities at Principia Biopharma Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-09-18||PRNB||Principia Biopharma Inc.||Buy||250,000||17.00||4,250,000|
|2018-03-08||BOLD||Audentes Therapeutics, Inc.||Sale||58,428||34.06||1,990,057|
|2018-03-12||BOLD||Audentes Therapeutics, Inc.||Sale||18,003||35.48||638,746|
|2018-03-09||BOLD||Audentes Therapeutics, Inc.||Sale||80,000||35.66||2,852,559|
|2018-03-06||BOLD||Audentes Therapeutics, Inc.||Sale||11,372||33.03||375,617|
|2018-03-05||BOLD||Audentes Therapeutics, Inc.||Sale||200||36.06||7,212|
|2018-03-02||BOLD||Audentes Therapeutics, Inc.||Sale||421,638||35.70||15,050,368|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Orbimed Capital Gp Iv Llc (10% Owner of Principia Biopharma Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.